Caladan Bio
New York, US · Founded 2023 · Delaware corporation · 21 employees on LinkedIn · 6 known investors
Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams. The company integrates bioreactor equipment with AI-driven process modeling software to support strain optimization and scale-up workflows.
Founders & leadership
Caladan Bio was founded in 2023 by Michael Kobida and Rob Jauquet.
Investors · 6
Reported raises · per SEC filings
Form D private placements$5.1M disclosed across 1 round · 2024
▶$5.1MraisedFeb 2024 · 7 investors · Other TechnologyRule 506(b)
▶$5.1MraisedFeb 2024 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. KobidaExecutive Officer, Director
- Robert JauquetExecutive Officer, Director
- Offering amount
- $5.1M
- Amount sold
- $5.1M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Day One Biopharmaceuticals4 shared keywordsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
IQVIA3 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Companies competing with Caladan Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Caladan Bio do?
- Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams. The company integrates bioreactor equipment with AI-driven process modeling software to support strain optimization and scale-up workflows.
- Who founded Caladan Bio?
- Caladan Bio was founded by Michael Kobida, Rob Jauquet in 2023.
- Who are Caladan Bio's investors?
- Caladan Bio's investors include Collaborative Fund, Lerer Hippeau, Ritual Capital, Twelve Below, Wireframe Ventures, Factorial Capital.
- How much funding has Caladan Bio raised?
- Caladan Bio has disclosed $5.1M raised across 1 round.
- Where is Caladan Bio headquartered?
- Caladan Bio is headquartered in New York, US.